Acromegaly is a rare hormonal disorder caused almost always by a growth hormone (GH)-secreting pituitary adenoma. Chronically elevated GH — and its downstream mediator IGF-1 — drive a distinct metabolic syndrome: progressive weight gain, insulin resistance, sleep apnoea, joint destruction, and cardiovascular risk. Conventional dieting barely touches acromegaly-related weight gain until GH is controlled. This article explains how the disease physiology drives weight problems, what dietary and lifestyle strategies actually help, how to exercise safely with damaged joints, and how South African patients can navigate the healthcare system. Always work with an endocrinologist — this is a surgical disease with pharmacological adjuncts, not a diet disease.
How Excess Growth Hormone Drives Weight Gain
GH has a paradoxical relationship with body composition. In childhood and adolescence it builds muscle and burns fat. In acromegaly the chronically supraphysiological GH levels produce a very different metabolic picture:
Acromegaly initially promotes lean mass gain — patients grow in all directions (enlarged hands, feet, jaw, soft tissue). But the accompanying insulin resistance progressively shifts the body toward fat accumulation, particularly visceral (abdominal) fat. IGF-1 drives cellular proliferation in soft tissue while GH-induced insulin resistance prevents normal fat mobilisation. The result is a patient who may look solid but carries significant hidden visceral adiposity.
GH-Induced Insulin Resistance
GH is an insulin counter-regulatory hormone. Chronically elevated GH directly antagonises insulin signalling in muscle, liver, and adipose tissue. Approximately 25–50% of acromegaly patients develop overt type 2 diabetes; many more have impaired glucose tolerance. This creates the same vicious cycle seen in metabolic syndrome: elevated insulin blocks fat burning, promotes fat storage, and drives appetite. Controlling blood glucose becomes as important as controlling GH.
Sleep Apnoea and the Weight–GH Feedback Loop
Over 60% of acromegaly patients have obstructive sleep apnoea, caused by macroglossia (enlarged tongue), soft tissue hypertrophy of the upper airway, and craniofacial changes. Sleep apnoea independently drives weight gain via ghrelin elevation (appetite hormone), leptin resistance, and cortisol dysregulation from sleep fragmentation. Untreated sleep apnoea makes weight loss almost impossible regardless of diet quality.
Joint Pain and Severely Restricted Mobility
GH excess causes articular cartilage thickening followed by premature degeneration. Acromegalic arthropathy affects the knees, hips, spine, and shoulders — often severely. Reduced physical activity from joint pain compounds metabolic dysfunction and accelerates weight gain.
Priority One: Control the GH Source
As with Cushing's syndrome, nutritional interventions have limited impact until the primary hormonal driver is addressed. GH normalisation typically follows one of three pathways:
Transsphenoidal pituitary surgery: First-line for most patients. Specialist neurosurgical centres in South Africa include Groote Schuur Hospital (Cape Town), Steve Biko Academic Hospital (Pretoria), and Inkosi Albert Luthuli Central Hospital (Durban). Private neurosurgeons operate at Netcare, Life, and Mediclinic facilities. Cure rates depend on tumour size — microadenomas have higher cure rates than macroadenomas.
Somatostatin analogues (SSAs): Octreotide LAR (Sandostatin LAR) or lanreotide (Somatuline) injected monthly reduce GH and IGF-1 in 55–65% of patients. Available in South Africa; often funded by medical aid for confirmed acromegaly (PMB condition). Common side effects include gallstones, steatorrhoea (fatty stools), and transient diarrhoea — all nutrition-relevant.
Pegvisomant (Somavert): A GH receptor antagonist that blocks GH action rather than reducing secretion. Normalises IGF-1 in over 90% of patients. Expensive; limited availability. Notable: it can cause mild weight gain in some patients initially, but insulin resistance often improves dramatically.
Radiotherapy: Adjunctive for residual tumour after surgery; GH normalisation may take 5–15 years. Hypopituitarism (GH deficiency, hypothyroidism, adrenal insufficiency) is a long-term risk requiring hormone replacement that affects nutritional needs.
Post-Radiotherapy Hypopituitarism Alert: If you have had pituitary radiotherapy and are now on cortisol replacement (hydrocortisone), thyroid replacement (levothyroxine), or growth hormone replacement, your dietary needs differ from pre-treatment acromegaly. Discuss with your endocrinologist before starting any calorie-restricted diet — adrenal insufficiency during caloric stress can be life-threatening.
Nutrition Strategy for Active Acromegaly
Low Glycaemic Index Diet — Non-Negotiable
Given the near-universal insulin resistance in active acromegaly, a low-GI dietary pattern is the single most impactful nutritional intervention. The goal is to flatten post-meal glucose spikes that would otherwise drive insulin surges, fat storage, and appetite dysregulation.
South African low-GI staples that work well:
Jungle Oats (rolled oats, not instant): GI ~55. Breakfast base — add psyllium husk to further blunt the glucose curve.
Baby potatoes cooked and cooled: Cooling converts starch to resistant starch, dropping GI significantly vs. hot mashed potato.
Whole grain rye bread (Sasko or similar): GI ~55, far lower than white bread (GI ~75).
Legumes — sugar beans, lentils, chickpeas: GI 30–48. Cheap protein-carbohydrate combination that sustains satiety. Sugar beans in morogo stew is a traditional Limpopo dish that works perfectly.
Basmati rice over white parboiled rice: GI difference of ~15 points matters across multiple daily meals.
Rooibos tea: Naturally caffeine-free, contains aspalathin which has shown mild anti-diabetic properties in animal studies. A useful sugar-free replacement for sweetened drinks.
Protein: Maintain Lean Mass Without Overloading Glucose
Target 1.3–1.8 g protein per kg body weight per day. Protein has minimal effect on blood glucose while preserving muscle during caloric deficit. Acromegaly patients often have above-average lean mass (GH is anabolic) — preserve this during treatment as it supports resting metabolic rate.
Practical sources:
Eggs (2–3 per day if lipids permit)
Pilchards in tomato sauce (R15–25/tin) — omega-3s also reduce cardiovascular risk, which is elevated in acromegaly
Skinless chicken, turkey mince
Low-fat cottage cheese or amasi (maas) — fermented milk with probiotic benefit, GI ~30
Biltong (lean, low-fat cuts) — high protein, negligible carbohydrate, portable
Limit Simple Sugars and Refined Starches Strictly
In acromegaly, white bread, white rice, sugary drinks, sweets, and fruit juice cause exaggerated post-meal glucose spikes due to underlying insulin resistance. These are not merely "unhealthy choices" — they are acutely harmful to metabolic control. Eliminate entirely during active disease.
Dietary Fat: Prioritise Unsaturated Fats
Acromegaly significantly elevates cardiovascular risk (cardiomyopathy, hypertension, left ventricular hypertrophy). A diet emphasising omega-3 and monounsaturated fats over saturated fat provides cardiovascular protection:
Oily fish twice weekly (pilchards, sardines, snoek)
Avocado (abundant and affordable in SA)
Olive oil for cooking
Limit red fatty meat and full-fat dairy
Somatostatin Analogue Side Effect Management
Octreotide LAR and lanreotide suppress pancreatic enzyme secretion and gallbladder motility. This causes:
Steatorrhoea (fatty, pale, floating stools): Reduce dietary fat to 30–40 g/day. Spread fat intake across all meals rather than in one sitting. Your gastroenterologist or endocrinologist may add pancreatic enzyme replacement (Creon) if malabsorption is significant.
Gallstone formation: Over 20% of patients on long-term SSAs develop gallstones. Maintain adequate dietary fat (zero fat diets paradoxically worsen gallstone risk by halting gallbladder contraction) — the sweet spot is moderate, evenly distributed fat intake.
Diarrhoea/loose stools (especially early): Usually resolves in 4–8 weeks. Soluble fibre (oats, psyllium, cooked vegetables) helps firm stool without worsening malabsorption.
Tip: If you are on somatostatin analogues and experiencing significant fatty stools, ask your endocrinologist about a faecal elastase test to check pancreatic exocrine function before attributing symptoms to diet alone.
Exercise with Acromegalic Arthropathy
Joint pain is the biggest physical barrier to activity in acromegaly. Standard high-impact exercise advice is often dangerous or impossible. Focus on joint-protecting modalities:
Exercise Type
Joint Impact
Recommended
SA Context
Swimming
Zero impact
Strongly yes
Municipal pools R15–30/session; Highveld heated indoor pools in winter
Water aerobics / hydrotherapy
Near-zero
Strongly yes
Available at Virgin Active, Planet Fitness
Stationary cycling
Low (if seat height correct)
Yes — saddle height critical for knee protection
Gym or home trainer; avoid outdoor cycling on rough SA roads
Walking on flat surfaces
Moderate
Yes, if tolerated
Mall walking on smooth floors is joint-kinder than pavement
Running / jogging
High
Avoid until joints assessed
—
Heavy weight training
High (compressive)
Avoid — consult physiotherapist first
—
Resistance bands / light weights
Low–moderate
Yes — preserves muscle mass
Bands R150–300 at Mr Price Sport, Game
A South African physiotherapist with experience in arthropathy (ask your rheumatologist or endocrinologist for a referral) can design an individualised program. SASP (South African Society of Physiotherapy) members can be found at saphysio.co.za.
Sleep Apnoea: The Hidden Weight-Loss Blocker
If you have acromegaly and are struggling to lose weight despite controlled GH and reasonable diet, undiagnosed or undertreated sleep apnoea may be the culprit. Signs include loud snoring, witnessed apnoea episodes, waking unrefreshed, daytime sleepiness, and morning headaches.
Request a sleep study (polysomnography) — available at sleep laboratories in major SA cities, covered by most medical aids under motivation
CPAP therapy normalises ghrelin/leptin balance within weeks of compliance — patients often report easier appetite control and improved energy for exercise
Weight loss and GH control both improve sleep apnoea — a virtuous cycle once started
Avoid alcohol, sedating antihistamines, and sleeping pills — all worsen upper airway muscle tone
Micronutrients and Cardiovascular Protection
Nutrient
Relevance in Acromegaly
SA Sources
Omega-3 fatty acids
Reduce cardiovascular risk, anti-inflammatory for joints
Blunts post-meal glucose spikes; supports SSA GI side effects
Oats, psyllium husk, sugar beans, lentils
Post-Treatment: Weight Loss After GH Normalisation
Once GH and IGF-1 are biochemically controlled — whether through surgery, medication, or both — the metabolic environment shifts. Insulin resistance typically improves markedly within 3–6 months, diabetes may partially or fully resolve, and appetite normalises. This is when conventional weight loss strategies become effective.
The post-treatment window has unique characteristics:
Metabolic rate resets: As GH normalises, the anabolic drive to retain fluid and tissue decreases. Expect some initial loss of water weight (2–4 kg in the first month post-surgery) that is not fat loss.
Insulin sensitivity improves progressively: Dietary carbohydrate tolerance often increases post-treatment, but continue low-GI eating — many patients retain some degree of insulin resistance long-term.
Joints may allow more activity: GH normalisation slows arthropathy progression and some patients report pain improvement within 6–12 months. Gradually increase exercise intensity as joints permit.
If diabetes resolves: Discuss medication adjustment with your endocrinologist and dietitian before reducing anti-diabetic drugs alongside dietary changes — hypoglycaemia risk is real.
Target weight loss rate post-treatment: 0.5–1 kg per week is sustainable and preserves lean mass. Faster loss risks muscle wasting, which is already a risk in acromegaly. A moderate caloric deficit of 500 kcal/day combined with low-GI eating and joint-friendly exercise achieves this reliably.
Monitoring: What to Track Beyond the Scale
IGF-1 and GH (every 3–6 months): The primary markers of disease control. Weight loss is directly linked to sustained GH normalisation.
Lipid profile annually: Acromegaly often causes dyslipidaemia (high triglycerides, low HDL). Normalises with GH control.
Echocardiogram (as recommended by cardiologist): Left ventricular hypertrophy and valvular abnormalities are common. Monitor cardiac function independent of weight.
Waist circumference: More sensitive than BMI for tracking visceral fat loss in acromegaly. Target below 94 cm (men) / 80 cm (women) per IDF criteria.
Bone density (DEXA): GH excess can affect bone quality; post-treatment DEXA at baseline and 2-yearly is reasonable.
South African Resources and Support
SEMDSA (Society of Endocrinology, Metabolism and Diabetes of South Africa): semdsa.co.za — endocrinologist directory, clinical guidelines
ADSA (Association for Dietetics in South Africa): adsa.org.za — find a registered dietitian experienced in endocrine conditions
Pituitary Foundation (international, English-language): pituitary.org.uk — patient guides, support groups; relevant SA chapter information
SASP (South African Society of Physiotherapy): saphysio.co.za — find a physiotherapist for joint-protective exercise programming
Medical aid PMB: Acromegaly with confirmed pituitary adenoma qualifies as a Prescribed Minimum Benefit (PMB) condition under the Medical Schemes Act. This entitles you to cover for diagnosis and treatment at cost. Motivate your medical aid with your endocrinologist's letter if claims are declined.
Acromegaly causes weight gain primarily through GH-driven insulin resistance, visceral fat accumulation, sleep apnoea, and reduced mobility from joint disease
Conventional weight loss approaches are largely ineffective until GH is biochemically controlled — surgery or somatostatin analogues come first
Low-GI diet is the most impactful nutritional intervention given near-universal insulin resistance
Manage somatostatin analogue side effects with moderate evenly distributed fat intake and soluble fibre
Exercise must be joint-protective — swimming, hydrotherapy, stationary cycling, and resistance bands rather than running or heavy weights
Post-treatment, conventional 0.5–1 kg/week weight loss targets become achievable as insulin resistance resolves
Track IGF-1, HbA1c, waist circumference, and cardiac function — not just body weight
This article is for informational purposes only and does not constitute medical advice. Acromegaly requires specialist endocrinological management. Always consult your endocrinologist, registered dietitian, and relevant specialists before making changes to your diet, medication, or exercise programme.